To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.
The global High-Throughput Screening Services for Drug Discovery market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淗igh-Throughput Screening Services for Drug Discovery Industry Forecast鈥� looks at past sales and reviews total world High-Throughput Screening Services for Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected High-Throughput Screening Services for Drug Discovery sales for 2023 through 2029. With High-Throughput Screening Services for Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High-Throughput Screening Services for Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global High-Throughput Screening Services for Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on High-Throughput Screening Services for Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global High-Throughput Screening Services for Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High-Throughput Screening Services for Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High-Throughput Screening Services for Drug Discovery.
United States market for High-Throughput Screening Services for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for High-Throughput Screening Services for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for High-Throughput Screening Services for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key High-Throughput Screening Services for Drug Discovery players cover Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of High-Throughput Screening Services for Drug Discovery market by product type, application, key players and key regions and countries.
Segmentation by Type:
Chemical-based HTS Assays
Biological-based HTS Assays
Cell-based HTS Assays
Genetic-based HTS Assays
Segmentation by Application:
Pharmaceutical Company
Biotechnology Company
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Chemical-based HTS Assays
Biological-based HTS Assays
Cell-based HTS Assays
Genetic-based HTS Assays
Segmentation by Application:
Pharmaceutical Company
Biotechnology Company
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global High-Throughput Screening Services for Drug Discovery Market Size 2019-2030
2.1.2 High-Throughput Screening Services for Drug Discovery Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for High-Throughput Screening Services for Drug Discovery by Country/Region, 2019, 2023 & 2030
2.2 High-Throughput Screening Services for Drug Discovery Segment by Type
2.2.1 Chemical-based HTS Assays
2.2.2 Biological-based HTS Assays
2.2.3 Cell-based HTS Assays
2.2.4 Genetic-based HTS Assays
2.3 High-Throughput Screening Services for Drug Discovery Market Size by Type
2.3.1 High-Throughput Screening Services for Drug Discovery Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global High-Throughput Screening Services for Drug Discovery Market Size Market Share by Type (2019-2024)
2.4 High-Throughput Screening Services for Drug Discovery Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.5 High-Throughput Screening Services for Drug Discovery Market Size by Application
2.5.1 High-Throughput Screening Services for Drug Discovery Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global High-Throughput Screening Services for Drug Discovery Market Size Market Share by Application (2019-2024)
3 High-Throughput Screening Services for Drug Discovery Market Size by Player
3.1 High-Throughput Screening Services for Drug Discovery Market Size Market Share by Player
3.1.1 Global High-Throughput Screening Services for Drug Discovery Revenue by Player (2019-2024)
3.1.2 Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Player (2019-2024)
3.2 Global High-Throughput Screening Services for Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 High-Throughput Screening Services for Drug Discovery by Region
4.1 High-Throughput Screening Services for Drug Discovery Market Size by Region (2019-2024)
4.2 Global High-Throughput Screening Services for Drug Discovery Annual Revenue by Country/Region (2019-2024)
4.3 Americas High-Throughput Screening Services for Drug Discovery Market Size Growth (2019-2024)
4.4 APAC High-Throughput Screening Services for Drug Discovery Market Size Growth (2019-2024)
4.5 Europe High-Throughput Screening Services for Drug Discovery Market Size Growth (2019-2024)
4.6 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size Growth (2019-2024)
5 Americas
5.1 Americas High-Throughput Screening Services for Drug Discovery Market Size by Country (2019-2024)
5.2 Americas High-Throughput Screening Services for Drug Discovery Market Size by Type (2019-2024)
5.3 Americas High-Throughput Screening Services for Drug Discovery Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC High-Throughput Screening Services for Drug Discovery Market Size by Region (2019-2024)
6.2 APAC High-Throughput Screening Services for Drug Discovery Market Size by Type (2019-2024)
6.3 APAC High-Throughput Screening Services for Drug Discovery Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (2019-2024)
7.2 Europe High-Throughput Screening Services for Drug Discovery Market Size by Type (2019-2024)
7.3 Europe High-Throughput Screening Services for Drug Discovery Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa High-Throughput Screening Services for Drug Discovery by Region (2019-2024)
8.2 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Type (2019-2024)
8.3 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global High-Throughput Screening Services for Drug Discovery Market Forecast
10.1 Global High-Throughput Screening Services for Drug Discovery Forecast by Region (2025-2030)
10.1.1 Global High-Throughput Screening Services for Drug Discovery Forecast by Region (2025-2030)
10.1.2 Americas High-Throughput Screening Services for Drug Discovery Forecast
10.1.3 APAC High-Throughput Screening Services for Drug Discovery Forecast
10.1.4 Europe High-Throughput Screening Services for Drug Discovery Forecast
10.1.5 Middle East & Africa High-Throughput Screening Services for Drug Discovery Forecast
10.2 Americas High-Throughput Screening Services for Drug Discovery Forecast by Country (2025-2030)
10.2.1 United States Market High-Throughput Screening Services for Drug Discovery Forecast
10.2.2 Canada Market High-Throughput Screening Services for Drug Discovery Forecast
10.2.3 Mexico Market High-Throughput Screening Services for Drug Discovery Forecast
10.2.4 Brazil Market High-Throughput Screening Services for Drug Discovery Forecast
10.3 APAC High-Throughput Screening Services for Drug Discovery Forecast by Region (2025-2030)
10.3.1 China High-Throughput Screening Services for Drug Discovery Market Forecast
10.3.2 Japan Market High-Throughput Screening Services for Drug Discovery Forecast
10.3.3 Korea Market High-Throughput Screening Services for Drug Discovery Forecast
10.3.4 Southeast Asia Market High-Throughput Screening Services for Drug Discovery Forecast
10.3.5 India Market High-Throughput Screening Services for Drug Discovery Forecast
10.3.6 Australia Market High-Throughput Screening Services for Drug Discovery Forecast
10.4 Europe High-Throughput Screening Services for Drug Discovery Forecast by Country (2025-2030)
10.4.1 Germany Market High-Throughput Screening Services for Drug Discovery Forecast
10.4.2 France Market High-Throughput Screening Services for Drug Discovery Forecast
10.4.3 UK Market High-Throughput Screening Services for Drug Discovery Forecast
10.4.4 Italy Market High-Throughput Screening Services for Drug Discovery Forecast
10.4.5 Russia Market High-Throughput Screening Services for Drug Discovery Forecast
10.5 Middle East & Africa High-Throughput Screening Services for Drug Discovery Forecast by Region (2025-2030)
10.5.1 Egypt Market High-Throughput Screening Services for Drug Discovery Forecast
10.5.2 South Africa Market High-Throughput Screening Services for Drug Discovery Forecast
10.5.3 Israel Market High-Throughput Screening Services for Drug Discovery Forecast
10.5.4 Turkey Market High-Throughput Screening Services for Drug Discovery Forecast
10.6 Global High-Throughput Screening Services for Drug Discovery Forecast by Type (2025-2030)
10.7 Global High-Throughput Screening Services for Drug Discovery Forecast by Application (2025-2030)
10.7.1 GCC Countries Market High-Throughput Screening Services for Drug Discovery Forecast
11 Key Players Analysis
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Information
11.1.2 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Product Offered
11.1.3 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eurofins Discovery Main Business Overview
11.1.5 Eurofins Discovery Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Product Offered
11.2.3 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Axcelead
11.3.1 Axcelead Company Information
11.3.2 Axcelead High-Throughput Screening Services for Drug Discovery Product Offered
11.3.3 Axcelead High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Axcelead Main Business Overview
11.3.5 Axcelead Latest Developments
11.4 NUVISAN
11.4.1 NUVISAN Company Information
11.4.2 NUVISAN High-Throughput Screening Services for Drug Discovery Product Offered
11.4.3 NUVISAN High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 NUVISAN Main Business Overview
11.4.5 NUVISAN Latest Developments
11.5 Axxam S.p.A.
11.5.1 Axxam S.p.A. Company Information
11.5.2 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Product Offered
11.5.3 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Axxam S.p.A. Main Business Overview
11.5.5 Axxam S.p.A. Latest Developments
11.6 Evotec
11.6.1 Evotec Company Information
11.6.2 Evotec High-Throughput Screening Services for Drug Discovery Product Offered
11.6.3 Evotec High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Evotec Main Business Overview
11.6.5 Evotec Latest Developments
11.7 Selvita
11.7.1 Selvita Company Information
11.7.2 Selvita High-Throughput Screening Services for Drug Discovery Product Offered
11.7.3 Selvita High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Selvita Main Business Overview
11.7.5 Selvita Latest Developments
11.8 Azenta Life Sciences
11.8.1 Azenta Life Sciences Company Information
11.8.2 Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Product Offered
11.8.3 Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Azenta Life Sciences Main Business Overview
11.8.5 Azenta Life Sciences Latest Developments
11.9 Bienta (Enamine)
11.9.1 Bienta (Enamine) Company Information
11.9.2 Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Product Offered
11.9.3 Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bienta (Enamine) Main Business Overview
11.9.5 Bienta (Enamine) Latest Developments
11.10 Cayman Chemical
11.10.1 Cayman Chemical Company Information
11.10.2 Cayman Chemical High-Throughput Screening Services for Drug Discovery Product Offered
11.10.3 Cayman Chemical High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cayman Chemical Main Business Overview
11.10.5 Cayman Chemical Latest Developments
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Information
11.11.2 Creative Biolabs High-Throughput Screening Services for Drug Discovery Product Offered
11.11.3 Creative Biolabs High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Creative Biolabs Main Business Overview
11.11.5 Creative Biolabs Latest Developments
11.12 Creative Bioarray
11.12.1 Creative Bioarray Company Information
11.12.2 Creative Bioarray High-Throughput Screening Services for Drug Discovery Product Offered
11.12.3 Creative Bioarray High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Creative Bioarray Main Business Overview
11.12.5 Creative Bioarray Latest Developments
11.13 BOC Sciences
11.13.1 BOC Sciences Company Information
11.13.2 BOC Sciences High-Throughput Screening Services for Drug Discovery Product Offered
11.13.3 BOC Sciences High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BOC Sciences Main Business Overview
11.13.5 BOC Sciences Latest Developments
11.14 MEDICILON
11.14.1 MEDICILON Company Information
11.14.2 MEDICILON High-Throughput Screening Services for Drug Discovery Product Offered
11.14.3 MEDICILON High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 MEDICILON Main Business Overview
11.14.5 MEDICILON Latest Developments
11.15 Domainex
11.15.1 Domainex Company Information
11.15.2 Domainex High-Throughput Screening Services for Drug Discovery Product Offered
11.15.3 Domainex High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Domainex Main Business Overview
11.15.5 Domainex Latest Developments
11.16 Creative Diagnostics
11.16.1 Creative Diagnostics Company Information
11.16.2 Creative Diagnostics High-Throughput Screening Services for Drug Discovery Product Offered
11.16.3 Creative Diagnostics High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Creative Diagnostics Main Business Overview
11.16.5 Creative Diagnostics Latest Developments
11.17 Multispan
11.17.1 Multispan Company Information
11.17.2 Multispan High-Throughput Screening Services for Drug Discovery Product Offered
11.17.3 Multispan High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Multispan Main Business Overview
11.17.5 Multispan Latest Developments
11.18 AntalGenics
11.18.1 AntalGenics Company Information
11.18.2 AntalGenics High-Throughput Screening Services for Drug Discovery Product Offered
11.18.3 AntalGenics High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 AntalGenics Main Business Overview
11.18.5 AntalGenics Latest Developments
11.19 Creative Biostructure
11.19.1 Creative Biostructure Company Information
11.19.2 Creative Biostructure High-Throughput Screening Services for Drug Discovery Product Offered
11.19.3 Creative Biostructure High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Creative Biostructure Main Business Overview
11.19.5 Creative Biostructure Latest Developments
11.20 BPS Bioscience
11.20.1 BPS Bioscience Company Information
11.20.2 BPS Bioscience High-Throughput Screening Services for Drug Discovery Product Offered
11.20.3 BPS Bioscience High-Throughput Screening Services for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 BPS Bioscience Main Business Overview
11.20.5 BPS Bioscience Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
